<table border="1"><tr><th>Name (IUPAC) systematic</th><td><ul><li>5 | H | -dibenzo-[ | b |, | f | ]-azepine-5-carboxamide</li></ul></td></tr><tr><th>CAS Number</th><td><ul><li>298-46-4 | 85756-57-6</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li> N03 | AF01</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>2554</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB00564</li></ul></td></tr><tr><th>ChemSpider</th><td><ul><li>2457</li></ul></td></tr><tr><th>UNII</th><td><ul><li>33CM23913M</li></ul></td></tr><tr><th>KEGG</th><td><ul><li>D00252</li></ul></td></tr><tr><th>ChEBI</th><td><ul><li>3387</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C | 15 | H | 12 | N | 2 | O</li></ul></td></tr><tr><th>Weight mol.</th><td><ul><li>236.27 g/mol</li></ul></td></tr><tr><th>P. of fusion</th><td><ul><li>190.2 °C</li></ul></td></tr><tr><th>Bioavailability</th><td><ul><li>80%</li></ul></td></tr><tr><th>Protein Union</th><td><ul><li>76%</li></ul></td></tr><tr><th>Metabolism</th><td><ul><li> Liver, via CYP3A4, active carbamazepin-10,11-epoxide</li></ul></td></tr><tr><th>Average life</th><td><ul><li>25–65 hours (after several administrations 12-17 hours)</li></ul></td></tr><tr><th>Excretion</th><td><ul><li>2-3% unchanged in urine</li></ul></td></tr><tr><th>Commercial name</th><td><ul><li> Carbatrol, Equestrian, Tegretal, Tegretol</li></ul></td></tr><tr><th>Cat. pregnancy</th><td><ul><li>Evidence of risk to the foetus, although the potential benefit of its use in pregnant women may be acceptable despite the likely risk only in some situations. It is at the discretion of the treating physician. | (USA)</li></ul></td></tr><tr><th>Legal status</th><td><ul><li> POM | (UK) | ☆ | -only | (USA)</li></ul></td></tr><tr><th>Adm. routes</th><td><ul><li>Oral</li></ul></td></tr></table>